Suchergebnisse - "Chiabudini, Marco"

PubPharm (32)

1

Final Results from RIBBIT : A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting

enthalten in: Breast care (Basel, Switzerland) | 2024

von Decker, T. | Zaiss, M. | Klein, D. | +12

2

First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer : Final results of the NEPTUN study

enthalten in: International journal of cancer | 2023

von Dechow, T. | Riera-Knorrenschild, J. | Hackanson, B. | +10

3

FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma : A novel validated prognostic score to facilitate treatment decision-making in real-world

enthalten in: International journal of cancer | 2023

von Marschner, N. | Hegewisch-Becker, S. | Reiser, M. | +10

4

First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer : Results of the NEPTUN study

enthalten in: Cancer medicine | 2021

von Dechow, T. | Riera-Knorrenschild, J. | Hackanson, B. | +9

5

Sleep Characteristics in Italian Children During Home Confinement Due to Covid-19 Outbreak

enthalten in: Clinical neuropsychiatry | 2021

von Bacaro, V. | Chiabudini, M. | Buonanno, C. | +4

6

Sleep characteristics in Italian children during home confinement due to COVID-19 outbreak

sonderdruck aus: Clinical neuropsychiatry | 2021

von Bacaro, V. | Chiabudini, M. | Buonanno, C. | +4

7

First‐line nab‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer : Results of the NEPTUN study

enthalten in: Cancer Medicine | 2021

von Dechow, T. | Riera‐Knorrenschild, J. | Hackanson, B. | +9

8

Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression

enthalten in: Cancer medicine | 2020

von Welt, A. | Wiesweg, M. | Theurer, S. | +11

9

Comparison of complex modeling strategies for prediction of a binary outcome based on a few, highly correlated predictors

enthalten in: Biometrical journal. Biometrische Zeitschrift | 2020

von Chiabudini, M. | Schumacher, M. | Graf, E.

10

Final results from IMPROVE : a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer

enthalten in: BMC cancer | 2020

von Decker, T. | Söling, U. | Hahn, A. | +11